Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates
Sign Up to like & getrecommendations! Published in 2022 at "Scientific Reports"
DOI: 10.21203/rs.3.rs-1315244/v1
Abstract: BIO 300, a pharmaceutical formulation of genistein, is being developed as a radiation countermeasure to treat hematopoietic acute radiation syndrome (H-ARS) and the delayed effects of acute radiation exposure (DEARE). Several studies have affirmed its… read more here.
Keywords: bio 300; formulation; oral powder; 300 oral ... See more keywords